tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kelly Shi, 83 are a BUY (96.51%), 3 are a HOLD (3.49%).
Analyst Kelly Shi, currently employed at JEFFERIES, carries an average stock price target met ratio of 53.94% that have a potential upside of 35.41% achieved within 201 days.
Kelly Shi’s has documented 173 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ASND, Ascendis Pharma AS at 31-Aug-2026.
Analyst best performing recommendations are on GRCL (GRACELL BIOTECHNOLOGIES).
The best stock recommendation documented was for MLTX (MOONLAKE IMMUNOTHERAPEUTICS) at 9/29/2025. The price target of $8 was fulfilled within 4 days with a profit of $1.75 (28%) receiving and performance score of 70.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Sell
$0.5
$0.5 (0.00%)
$0.5
3 years 6 months 4 days ago
(03-Apr-2023)
1/4 (25%)
$0.36 (257.14%)
2
Hold
$0.15
$0.15 (0.00%)
$2
3 years 8 months 26 days ago
(11-Jan-2023)
1/4 (25%)
$-0.01 (-6.25%)
8
Buy
$19
$18.86 (13471.43%)
$19
4 years 9 months 4 days ago
(03-Jan-2022)
0/5 (0%)
$14.39 (153.53%)
Sell
$21
5 years 28 days ago
(09-Sep-2021)
2/2 (100%)
$0.83 (4.65%)
18
Buy
$30
$29.99 (299900.00%)
$30
5 years 1 months 13 days ago
(24-Aug-2021)
0/2 (0%)
$11.69 (64.34%)
Which stock is Kelly Shi most bullish on?
What Year was the first public recommendation made by Kelly Shi?
